Clinical Trial Update: Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Trastuzumab Rezetecan in patients with urachal cancer and other advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urachal Cancer

Drugs mentioned

• Trastuzumab Rezetecan

Snippet

Sponsor: Sheng Zhang | Conditions: Urachal Cancer, Advanced Solid Tumor Cancer | Phase 2 | Status: RECRUITING